Trending

#Multiple_Sites

Latest posts tagged with #Multiple_Sites on Bluesky

Latest Top
Trending

Posts tagged #Multiple_Sites

Preview
Ascletis Gains FDA Clearance for Groundbreaking Diabetes Study of ASC30 Ascletis Pharma receives FDA IND approval for a Phase II trial of ASC30, a potential GLP-1 therapy for diabetes. Start of enrollment is anticipated in early 2026.

Ascletis Gains FDA Clearance for Groundbreaking Diabetes Study of ASC30 #USA #Ascletis #ASC30 #FDA_IND #Multiple_Sites

0 0 0 0